Literature DB >> 11731429

Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study.

P Xiong1, M L Bondy, D Li, H Shen, L E Wang, S E Singletary, M R Spitz, Q Wei.   

Abstract

Mounting epidemiological evidence suggests that smoking may play a role in the etiology of breast cancer. Because smoking-related DNA adducts are detectable in both normal and malignant breast tissues, we hypothesized that breast cancer patients may be sensitive to tobacco-induced carcinogenesis, and this sensitivity could be modulated by variants of metabolic genes. To test this hypothesis, we evaluated benzo(a)pyrene diol-epoxide (BPDE)-induced mutagen sensitivity and polymorphisms of GSTM1 and GSTT1 in a pilot case-control study of breast cancer. Short-term cell cultures were established from blood samples of 100 female breast cancer patients and 105 healthy controls. After 5 h of in vitro exposure to 4 microM of BPDE, we harvested the lymphocytes for cytogenetic evaluation and recorded and compared the frequency of BPDE-induced chromatid breaks between cases and controls. We used a multiplex PCR-based assay to simultaneously detect polymorphisms of GSTM1 and GSTT1 from genomic DNA. We performed univariate and multivariate logistic regression analyses and calculated odds ratios (OR) and 95% confidence intervals (CIs). Cases had a significantly higher frequency of chromatid breaks than did controls (P < 0.0001). The level of chromatid breaks greater than the median value of controls was associated with a >3-fold increased risk of breast cancer [adjusted odds ratio (ORadj) = 3.11; 95% CI = 1.72-5.64]. The risk was more pronounced in those who were < 45 years (ORadj = 4.79; 95% CI = 1.87-12.3), ever-smokers (ORadj = 5.55; 95% CI = 1.85-16.6), alcohol drinkers (ORadj = 4.64; 95% CI = 1.70-12.7), and those who had the GSTT1 null variant (ORadj = 8.01; 95% CI = 1.16-55.3). These data suggest that sensitivity to BPDE-induced chromosomal aberrations may contribute to the risk of developing breast cancer, and such sensitivity may be modulated by both genetic and environmental factors. Larger studies are needed to confirm our findings.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731429

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Lack of association between GSTT1 polymorphism and endogenous or benzo[a]pyrene-induced sister chromatid exchanges as analyzed in metaphase or G2-phase lymphocytes.

Authors:  V I Hatzi; G I Terzoudi; C Stavropoulou; S I Malik; V Makropoulos; G E Pantelias
Journal:  Mol Biol Rep       Date:  2010-11-25       Impact factor: 2.316

2.  Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.

Authors:  Tasha R Smith; Wen Liu-Mares; Beth O Van Emburgh; Edward A Levine; Glenn O Allen; Jeff W Hill; Isildinha M Reis; Laura A Kresty; Mark D Pegram; Mark S Miller; Jennifer J Hu
Journal:  Carcinogenesis       Date:  2011-06-23       Impact factor: 4.944

3.  Deregulation of NR2E3, an orphan nuclear receptor, by benzo(a)pyrene-induced oxidative stress is associated with histone modification status change of the estrogen receptor gene promoter.

Authors:  Tilak Khanal; Dasom Kim; Abby Johnson; Divaker Choubey; Kyounghyun Kim
Journal:  Toxicol Lett       Date:  2015-07-03       Impact factor: 4.372

4.  Mutagen sensitivity, tobacco smoking and breast cancer risk: a case-control study.

Authors:  Ourania Kosti; Celia Byrne; Katherine L Meeker; Kenshata M Watkins; Christopher A Loffredo; Peter G Shields; Marc D Schwartz; Shawna C Willey; Costanza Cocilovo; Yun-Ling Zheng
Journal:  Carcinogenesis       Date:  2010-01-28       Impact factor: 4.944

5.  Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancer.

Authors:  Jean J Latimer; Jennifer M Johnson; Crystal M Kelly; Tiffany D Miles; Kelly A Beaudry-Rodgers; Nancy A Lalanne; Victor G Vogel; Amal Kanbour-Shakir; Joseph L Kelley; Ronald R Johnson; Stephen G Grant
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

6.  Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier.

Authors:  Stephen G Grant; Rubina Das; Christina M Cerceo; Wendy S Rubinstein; Jean J Latimer
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

7.  Cell-type-specific level of DNA nucleotide excision repair in primary human mammary and ovarian epithelial cell cultures.

Authors:  Jean J Latimer; Jennifer M Johnson; Tiffany D Miles; Jason M Dimsdale; Robert P Edwards; Joseph L Kelley; Stephen G Grant
Journal:  Cell Tissue Res       Date:  2008-06-25       Impact factor: 5.249

8.  Association of the nibrin gene (NBN) variants with breast cancer.

Authors:  Hakan Uzunoglu; Tugcan Korak; Emel Ergul; Nihal Uren; Ali Sazci; N Zafer Utkan; Ertuğrul Kargi; Çağri Triyaki; Oktay Yirmibesoglu
Journal:  Biomed Rep       Date:  2016-01-25

9.  Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years.

Authors:  Jiachun Lu; Qingyi Wei; Melissa L Bondy; Abenaa M Brewster; Therese B Bevers; Tse-Kuan Yu; Thomas A Buchholz; Funda Meric-Bernstam; Kelly K Hunt; S Eva Singletary; Li-E Wang
Journal:  Breast Cancer Res Treat       Date:  2007-09-13       Impact factor: 4.872

Review 10.  BRCA1 and p53: compensatory roles in DNA repair.

Authors:  Anne-Renee Hartman; James M Ford
Journal:  J Mol Med (Berl)       Date:  2003-09-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.